Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 7 | BMC Musculoskeletal Disorders

Fig. 7

From: The effect of anti-IL-6 receptor antibody for the treatment of McH-lpr/lpr-RA1 mice that spontaneously developed destructive arthritis and enthesitis

Fig. 7

Quantitative analyses of signal intensity of IVIS at week 10, 14, 18. At week 14, the signal intensity of IVIS of ankles and foots is significantly lower in MR16–1 treatment group, compared with the control group. There are no significant changes in week 10 and 18 in both groups. Results are expressed as the mean ± standard error (n = 5 mice per group). Representative data are shown from three independent experiments with similar results. * p < 0.05 by two-way ANOVA with Dunn’s multiple comparison test

Back to article page